Baird raised the firm’s price target on iRhythm (IRTC) to $175 from $166 and keeps an Outperform rating on the shares. The firm updated its model following beat and raise Q1 results with its thesis remaining intact.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRTC:
- iRhythm price target lowered to $175 from $215 at JPMorgan
- iRhythm price target lowered to $185 from $225 at Oppenheimer
- iRhythm price target lowered to $160 from $170 at Evercore ISI
- iRhythm price target raised to $255 from $254 at Needham
- iRhythm price target lowered to $180 from $198 at Canaccord